Advanced in Monkeypox

Hongzhou Q. Lu

2901 Caolang Road, 
Shanghai, CN 
Advanced in Monkeypox
2901 Caolang Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Hongzhou Lu practices in Shanghai, China. Lu is rated as an Advanced expert by MediFind in the treatment of Monkeypox. Their top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Pneumonia.

Their clinical research consists of co-authoring 498 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 11 articles in the study of Monkeypox.

Locations

2901 Caolang Road, Shanghai, 201508, China
Other Locations
No. 18 North Third Ring Rd, Beijing, 100029, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I Clinical Study on the Safety, Tolerability and Pharmacokinetics of SI-F019 Recombinant Human Bivalent ACE2-Fc Fusion Protein Injection in a Single Dose in Healthy Subjects
A Phase I Clinical Study on the Safety, Tolerability and Pharmacokinetics of SI-F019 Recombinant Human Bivalent ACE2-Fc Fusion Protein Injection in a Single Dose in Healthy Subjects
Enrollment Status: Completed
Publish Date: December 13, 2022
Intervention Type: Drug
Study Phase: Phase 1
Efficacy and Safety of Albuvirtide for Injection Combined With LPV/r for Treatment of HIV-1-Infected Patients Failed First-line Antiretroviral Therapy
Efficacy and Safety of Albuvirtide for Injection Combined With LPV/r for Treatment of HIV-1-Infected Patients Failed First-line Antiretroviral Therapy
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Immunogenicity of a Single Dose of MW33 Injection in Healthy Subjects
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Immunogenicity of a Single Dose of MW33 Injection in Healthy Subjects
Enrollment Status: Completed
Publish Date: February 26, 2021
Intervention Type: Combination product
Study Phase: Phase 1
View 2 Less Clinical Trials

498 Total Publications

Chinese expert consensus on the combined use of antiviral drugs for novel coronavirus infection.
Chinese expert consensus on the combined use of antiviral drugs for novel coronavirus infection.
Journal: Bioscience trends
Published: August 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lu's expertise for a condition
ConditionClose
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile